Summary

The United Arab Emirates (UAE) has become a significant center for fertility in the region, with a market dominated by premium clinics found mainly in Dubai and Abu Dhabi. Facilities like ART Fertility Clinics, Fakih IVF, and Bourn Hall Fertility Center provide cutting-edge assisted reproductive technologies (ART) and serve both local Emirati clients and patients from abroad. The UAE is strategically promoting fertility tourism, utilizing its exceptional infrastructure, efficient visa processes, and high-quality healthcare services to draw individuals from the Middle East, South Asia, and Africa. Clinics commonly package IVF services with personal concierge support, establishing the UAE as a key location for reproductive healthcare and wellness. The development of IVF in the country gained momentum after the year 2000, especially after the enactment of Federal Law No. 11 in 2008 and subsequent reforms that broadened access and clarified the licensing requirements for fertilization facilities. Recent updates, like Federal Decree Law No. 17 of 2023, have made access more liberal, allowing unmarried non-Muslim couples to pursue IVF and facilitating the regulated import/export of gametes. These modifications indicate a wider trend toward inclusivity and progress in medical practices. Assisted Reproductive Technology (ART) in the UAE includes various clinical methods aimed at solving infertility issues, such as ovulation stimulation, intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete freezing, and embryo freezing. The Ministry of Health and Prevention and regional health agencies supervise ART services, ensuring they follow ethical standards and maintain clinical safety. Research and development initiatives are increasingly prioritizing the adoption of laboratory technologies. Clinics are incorporating AI-assisted embryo evaluation, time-lapse imaging incubators, and non-invasive genetic testing to improve success rates and tailor treatments. Events like the Trust Fertility & Gynecology Conference and ART Fertility Symposium highlight these advancements, underscoring the UAE’s goal of becoming a leader in reproductive healthcare. According to the research report, "UAE Fertility Service Market Overview, 2030," published by Bonafide Research, the UAE Fertility Service market is anticipated to grow at 10.77% CAGR from 2025 to 2030. With more than 85% of the populace being foreign-born residents, fertility services have developed to meet varied cultural, legal, and medical requirements. Institutions like Fakih IVF and Bourn Hall Dubai are at the forefront of the industry, providing cutting-edge assisted reproductive technologies (ART) such as IVF, ICSI, IUI, donor programs, and genetic testing. Fakih IVF operates in Dubai, Abu Dhabi, and Al Ain and is recognized for its innovative embryo scope technology and customized treatment plans. Bourn Hall Dubai, associated with Mediclinic and the heritage of the UK’s first IVF clinic, combines modern embryology laboratories with empathetic, culturally aware treatment. The UAE is swiftly establishing itself as a key destination for fertility tourism. Both Dubai and Abu Dhabi provide bundled treatment options, personalized services, and simplified medical visa processes, drawing patients from the Middle East, Africa, South Asia, and elsewhere. Initiatives such as the Dubai Health Experience (DXH) and Abu Dhabi’s Medical Tourism e-Portal back fertility tourism by promoting high-quality and budget-friendly care in upscale environments. Favorable visa regulations and multilingual medical personnel further boost the attractiveness of this sector. Adherence to regulations is maintained through strict guidelines managed by the Dubai Health Authority (DHA) and Health Authority Abu Dhabi (HAAD). The 2024 DHA regulations for fertility facilities specify requirements for licensing, personnel, equipment, and procedures. Meanwhile, Federal Decree Law No. 17 of 2023 allows ART access for unmarried non-Muslim couples under certain regulated circumstances. Clinics are required to follow ethical standards regarding gamete usage, embryo transfers, and genetic assessments, guaranteeing safety and openness. A of clinical proficiency, clear regulations, and strategic initiatives position the UAE as an emerging leader in the field of reproductive healthcare. In the UAE fertility service by procedure is divided into IVF with ICSI, IUI, IVF without ICSI, Surrogacy and Others, assisted reproductive technologies are becoming more advanced and are heavily monitored, with IVF combined with intracytoplasmic sperm injection now being the primary method in top clinics like Fakih IVF, Bourn Hall Dubai, and ART Fertility Clinics. ICSI is frequently utilized to tackle male infertility issues and improve fertilization results, often included in standard IVF packages at little extra cost. The prevalent use of ICSI indicates both a preference among healthcare professionals and a patient interest in achieving better success rates, particularly for couples dealing with sperm movement or shape challenges. Intrauterine insemination is also broadly accessible and viewed as a budget-friendly, less invasive initial treatment. With costs per cycle ranging from USD 800 to 1,500, IUI is suitable for couples with mild fertility problems, single women, and those opting for donor sperm. Clinics in Dubai and Ras Al-Khaimah provide customized IUI options, usually combined with ovulation tracking and sperm preparation, making it a sensible choice before moving on to IVF.IVF that does not utilize ICSI is rarely performed, generally reserved for younger couples who have excellent sperm quality and no past issues with fertilization. Although it can be done, it is not commonly chosen compared to the popularity of ICSI-enhanced methods. Surrogacy, which was previously prohibited, has recently been legalized under Federal Decree Law No. 17 of 2023 but remains strictly regulated. Only couples using their own eggs and sperm are allowed to pursue surrogacy, and the surrogate must be a UAE resident aged between 25 and 35 with a clean medical and legal history. Regulatory approval is essential, and the use of donor gametes remains forbidden, which limits access to surrogacy. In the United Arab Emirates fertility service by cause of infertility is divided into Male Infertility and Female Infertility, there is a significant prevalence of male infertility among expatriates, influenced by a combination of lifestyle choices, environmental conditions, and job-related factors. Expatriates, who make up more than 85% of the country’s residents, encounter increased dangers owing to demanding work schedules, heightened stress levels, unhealthy eating habits, tobacco use, and exposure to harsh weather and pollutants. More cases of issues like oligospermia, asthenozoospermia, and non-obstructive azoospermia are being identified, with facilities such as Fakih IVF and ART Fertility Clinics noticing a rise in male infertility instances. Sophisticated testing methods, such as DNA fragmentation analysis and hormonal assessments, are now common practice, while AI-driven sperm detection systems like Sperm SearchAI have exhibited encouraging outcomes in identifying viable sperm in difficult scenarios. These advancements are particularly important in the UAE, where obtaining donor sperm is not allowed, making biological options the sole feasible means for many couples seeking to become parents. There is also an increase in female infertility, driven by postponed childbirth, hormonal issues, and changing lifestyles. Women from both Emirati and expatriate backgrounds are increasingly experiencing ailments like polycystic ovary syndrome (PCOS), endometriosis, and reduced ovarian reserve. The fertility rate in the UAE has seen a significant decline from 5.4 children per woman in 2012 to merely 1.49 in 2022 raising concerns at the national level and initiating discussions about reproductive health policies. Factors such as later marriages, prioritization of careers, and escalating obesity rates are leading to lower fertility rates, particularly in women aged 35 and older. Fertility clinics are adapting by offering broader access to egg freezing, tailored IVF treatments, and preimplantation genetic testing to enhance success rates. In the UAE fertility service by end user is divided into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, private fertility centers especially Fakih IVF Fertility Center dominate the scene in reproductive healthcare, providing state-of-the-art assisted reproductive technologies (ART) and tailored treatment strategies across Dubai, Abu Dhabi, and Al Ain. Fakih IVF was the first private IVF center established in Dubai and continues to be a leader in the region, incorporating AI-assisted embryo assessment, genetic testing, and microfluidic sperm selection in its methods. Its in-house genetics lab and high success rates have made it a top choice for both Emirati and foreign patients seeking innovative fertility solutions. Additional private centers like ART Fertility Clinics and Bourn Hall Dubai bolster the UAE's status as a hub for fertility tourism, merging high-quality clinical services with customized care options. Hospitals take a less prominent role in providing ART, generally focusing on diagnostics, fertility maintenance, and collaborative treatment. Institutions like Burjeel Hospital and NMC Specialty Hospital offer services like IVF and ICSI, but their fertility departments tend to be smaller and less specialized compared to independent clinics. Public hospitals under the SEHA umbrella, such as Tawam and Corniche, play a part by offering subsidized care and surgical procedures, especially for fertility preservation linked to cancer and for complicated reproductive issues. Surgical facilities often part of hospitals or fertility clinics deal with issues related to infertility like endometriosis, fibroids, and blocked fallopian tubes. Operations such as laparoscopy, hysteroscopy, and micro-TESE are crucial for restoring natural fertility or improving ART results. These services are mainly found in urban areas and are increasingly combined with diagnostic and treatment pathways. Research laboratories in the UAE are few but are slowly growing. Considered in this report • Historic Year: 2019 • Base year: 2024 • Estimated year: 2025 • Forecast year: 2030 Aspects covered in this report • Fertility Services Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Procedure • IVF with ICSI • IUI • IVF without ICSI • Surrogacy • Others By Service • Fresh Non-Donor • Frozen Non-Donor • Egg and Embryo Banking • Fresh Donor • Frozen Donor By Cause of Infertility • Male Infertility • Female Infertility By End User • Fertility Clinics • Hospitals • Surgical Centers • Clinical Research Institutes

ページTOPに戻る

Table of Contents

Table of Content

1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. UAE Geography
4.1. Population Distribution Table
4.2. UAE Macro Economic Indicators
5. Market Dynamics
5.1. Key Insights
5.2. Recent Developments
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Supply chain Analysis
5.7. Policy & Regulatory Framework
5.8. Industry Experts Views
6. UAE Fertility Service Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast, By Procedure
6.3. Market Size and Forecast, By Cause of Infertility
6.4. Market Size and Forecast, By End User
6.5. Market Size and Forecast, By Region
7. UAE Fertility Service Market Segmentations
7.1. UAE Fertility Service Market, By Procedure
7.1.1. UAE Fertility Service Market Size, By IVF with ICSI, 2019-2030
7.1.2. UAE Fertility Service Market Size, By IUI, 2019-2030
7.1.3. UAE Fertility Service Market Size, By IVF without ICSI, 2019-2030
7.1.4. UAE Fertility Service Market Size, By Surrogacy, 2019-2030
7.1.5. UAE Fertility Service Market Size, By Others, 2019-2030
7.2. UAE Fertility Service Market, By Cause of Infertility
7.2.1. UAE Fertility Service Market Size, By Male Infertility, 2019-2030
7.2.2. UAE Fertility Service Market Size, By Female Infertility, 2019-2030
7.3. UAE Fertility Service Market, By End User
7.3.1. UAE Fertility Service Market Size, By Fertility Clinics, 2019-2030
7.3.2. UAE Fertility Service Market Size, By Hospitals, 2019-2030
7.3.3. UAE Fertility Service Market Size, By Surgical Centers, 2019-2030
7.3.4. UAE Fertility Service Market Size, By Clinical Research Institutes, 2019-2030
7.4. UAE Fertility Service Market, By Region
7.4.1. UAE Fertility Service Market Size, By North, 2019-2030
7.4.2. UAE Fertility Service Market Size, By East, 2019-2030
7.4.3. UAE Fertility Service Market Size, By West, 2019-2030
7.4.4. UAE Fertility Service Market Size, By South, 2019-2030
8. UAE Fertility Service Market Opportunity Assessment
8.1. By Procedure, 2025 to 2030
8.2. By Cause of Infertility, 2025 to 2030
8.3. By End User, 2025 to 2030
8.4. By Region, 2025 to 2030
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.1.1. Company Snapshot
9.2.1.2. Company Overview
9.2.1.3. Financial Highlights
9.2.1.4. Geographic Insights
9.2.1.5. Business Segment & Performance
9.2.1.6. Product Portfolio
9.2.1.7. Key Executives
9.2.1.8. Strategic Moves & Developments
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: UAE Fertility Service Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 2: Market Attractiveness Index, By Procedure
Figure 3: Market Attractiveness Index, By Cause of Infertility
Figure 4: Market Attractiveness Index, By End User
Figure 5: Market Attractiveness Index, By Region
Figure 6: Porter's Five Forces of UAE Fertility Service Market


List of Tables

Table 1: Influencing Factors for Fertility Service Market, 2024
Table 2: UAE Fertility Service Market Size and Forecast, By Procedure (2019 to 2030F) (In USD Million)
Table 3: UAE Fertility Service Market Size and Forecast, By Cause of Infertility (2019 to 2030F) (In USD Million)
Table 4: UAE Fertility Service Market Size and Forecast, By End User (2019 to 2030F) (In USD Million)
Table 5: UAE Fertility Service Market Size and Forecast, By Region (2019 to 2030F) (In USD Million)
Table 6: UAE Fertility Service Market Size of IVF with ICSI (2019 to 2030) in USD Million
Table 7: UAE Fertility Service Market Size of IUI (2019 to 2030) in USD Million
Table 8: UAE Fertility Service Market Size of IVF without ICSI (2019 to 2030) in USD Million
Table 9: UAE Fertility Service Market Size of Surrogacy (2019 to 2030) in USD Million
Table 10: UAE Fertility Service Market Size of Others (2019 to 2030) in USD Million
Table 11: UAE Fertility Service Market Size of Male Infertility (2019 to 2030) in USD Million
Table 12: UAE Fertility Service Market Size of Female Infertility (2019 to 2030) in USD Million
Table 13: UAE Fertility Service Market Size of Fertility Clinics (2019 to 2030) in USD Million
Table 14: UAE Fertility Service Market Size of Hospitals (2019 to 2030) in USD Million
Table 15: UAE Fertility Service Market Size of Surgical Centers (2019 to 2030) in USD Million
Table 16: UAE Fertility Service Market Size of Clinical Research Institutes (2019 to 2030) in USD Million
Table 17: UAE Fertility Service Market Size of North (2019 to 2030) in USD Million
Table 18: UAE Fertility Service Market Size of East (2019 to 2030) in USD Million
Table 19: UAE Fertility Service Market Size of West (2019 to 2030) in USD Million
Table 20: UAE Fertility Service Market Size of South (2019 to 2030) in USD Million